Nipro Zukünftiges Wachstum

6.4%

Wachstumsrate der Gewinne

6.3%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	17.5%
Wachstumsrate der Einnahmen	3.8%
Zukünftige Eigenkapitalrendite	10.0%
Analystenabdeckung	Low
Zuletzt aktualisiert	n/a

Keine Aktualisierungen

Gewinn- und Umsatzwachstumsprognosen

OTCPK:NPRR.F - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2025	579,574	21,335	9,354	71,295	3
3/31/2024	557,900	19,018	3,942	65,034	3
3/31/2023	529,975	16,461	-10,132	53,319	3
3/31/2022	494,789	13,455	-11,589	68,214	N/A
12/31/2021	483,831	14,870	N/A	N/A	N/A
9/30/2021	475,425	16,039	-8,861	68,386	N/A
6/30/2021	464,635	14,480	N/A	N/A	N/A
3/31/2021	455,559	14,209	14,911	66,093	N/A
12/31/2020	446,879	-12,762	N/A	N/A	N/A
9/30/2020	442,102	-12,694	-6,350	45,200	N/A
6/30/2020	441,680	-12,044	N/A	N/A	N/A
3/31/2020	442,516	-12,281	-20,697	37,246	N/A
12/31/2019	441,808	13,142	N/A	N/A	N/A
9/30/2019	440,742	10,407	-16,459	36,984	N/A
6/30/2019	432,959	10,246	N/A	N/A	N/A
3/31/2019	426,399	12,136	-14,618	41,362	N/A
12/31/2018	422,840	7,857	N/A	N/A	N/A
9/30/2018	415,819	11,162	-23,410	39,660	N/A
6/30/2018	405,046	12,269	N/A	N/A	N/A
3/31/2018	395,397	11,829	-21,336	41,046	N/A
12/31/2017	383,381	11,099	N/A	N/A	N/A
9/30/2017	370,021	16,705	-33,705	38,635	N/A
6/30/2017	364,127	15,375	N/A	N/A	N/A
3/31/2017	359,699	11,346	-30,674	33,472	N/A
12/31/2016	362,776	19,821	N/A	N/A	N/A
9/30/2016	364,701	16,995	-10,739	36,509	N/A
6/30/2016	367,677	16,027	N/A	N/A	N/A
3/31/2016	366,650	19,718	-12,002	29,934	N/A
12/31/2015	359,044	11,918	N/A	N/A	N/A
9/30/2015	350,113	12,646	N/A	34,812	N/A
6/30/2015	337,757	15,122	N/A	N/A	N/A

Einkommen vs. Sparrate: NPRR.F's forecast earnings growth (6.4% per year) is above the savings rate (1.9%).

Ertrag vs. Markt: NPRR.F's earnings (6.4% per year) are forecast to grow slower than the US market (12.5% per year).

Hohe Wachstumserträge: NPRR.F's earnings are forecast to grow, but not significantly.

Einnahmen vs. Markt: NPRR.F's revenue (3.8% per year) is forecast to grow slower than the US market (7.8% per year).

Hohe Wachstumseinnahmen: NPRR.F's revenue (3.8% per year) is forecast to grow slower than 20% per year.

Künftige Eigenkapitalrendite: NPRR.F's Return on Equity is forecast to be low in 3 years time (10%).